Back to company

GB PHARMA ApS: Financial statements 2016

CVR: 36054220

GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -425,648 and a net result of DKK -664,356. Equity amounted to DKK -2,686,576.

Gross Profit
-425,648 kr.
Profit/Loss
-664,356 kr.
Equity
-2,686,576 kr.
Total Assets
203,867 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GB PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

GB PHARMA ApS publishes interim reportJun 8, 2016

GB PHARMA ApS has published its interim report for the period July 28, 2014 – December 31, 2015.

Benny Roland Eriksen leaves the board of GB PHARMA ApSMay 26, 2016

As of May 26, 2016, Benny Roland Eriksen has left the board of directors of GB PHARMA ApS.

Gunnar Kjems joins GB PHARMA ApS as adm. dir.May 26, 2016

As of May 26, 2016, Gunnar Kjems is registered as adm. dir. of GB PHARMA ApS.

Benny Roland Eriksen steps down as adm. dir. of GB PHARMA ApSMay 26, 2016

As of May 26, 2016, Benny Roland Eriksen has stepped down as adm. dir. of GB PHARMA ApS.

About GB PHARMA ApS

GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The company is owned by Gunnar Kjems. The company has 0 employees. In 2025, the company reported revenue of DKK 0 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity amounted to DKK -1,902,842.